- Home
- BHAT vs GTBP Comparison
BHAT vs GTBP Comparison
Compare BHAT & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHAT
- GTBP
- Stock Information
- Founded
- BHAT 2010
- GTBP 1965
- Country
- BHAT China
- GTBP United States
- Employees
- BHAT N/A
- GTBP N/A
- Industry
- BHAT Recreational Games/Products/Toys
- GTBP Biotechnology: Pharmaceutical Preparations
- Sector
- BHAT Consumer Discretionary
- GTBP Health Care
- Exchange
- BHAT Nasdaq
- GTBP Nasdaq
- Market Cap
- BHAT 12.3M
- GTBP 5.5M
- IPO Year
- BHAT 2019
- GTBP N/A
- Fundamental
- Price
- BHAT $1.66
- GTBP $0.79
- Analyst Decision
- BHAT
- GTBP Strong Buy
- Analyst Count
- BHAT 0
- GTBP 1
- Target Price
- BHAT N/A
- GTBP $11.00
- AVG Volume (30 Days)
- BHAT 1.1M
- GTBP 449.7K
- Earning Date
- BHAT 04-30-2025
- GTBP 11-13-2025
- Dividend Yield
- BHAT N/A
- GTBP N/A
- EPS Growth
- BHAT N/A
- GTBP N/A
- EPS
- BHAT N/A
- GTBP N/A
- Revenue
- BHAT $18,724,190.00
- GTBP N/A
- Revenue This Year
- BHAT N/A
- GTBP N/A
- Revenue Next Year
- BHAT N/A
- GTBP N/A
- P/E Ratio
- BHAT N/A
- GTBP N/A
- Revenue Growth
- BHAT N/A
- GTBP N/A
- 52 Week Low
- BHAT $1.51
- GTBP $0.63
- 52 Week High
- BHAT $45.00
- GTBP $4.10
- Technical
- Relative Strength Index (RSI)
- BHAT 46.47
- GTBP 29.57
- Support Level
- BHAT $1.62
- GTBP $0.63
- Resistance Level
- BHAT $1.83
- GTBP $0.85
- Average True Range (ATR)
- BHAT 0.18
- GTBP 0.10
- MACD
- BHAT 0.01
- GTBP 0.03
- Stochastic Oscillator
- BHAT 18.00
- GTBP 31.22
About BHAT Blue Hat Interactive Entertainment Technology
Blue Hat Interactive Entertainment Technology is focused on commodity trading, including chemicals, jewelry, and precious metals such as gold. It operates a gold and diamond trading and supply chain business. Its business model encompasses physical gold trading, diamond trading, gold derivatives trading, and the development of AI-enabled trading platforms. Its segments include Diamond trading, Commodity trading, Information service, Interactive toys - animation series, and Interactive toys - game series. It derives revenue from Diamond trading. The majority of its revenues are generated in PRC.
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.